Understanding Fragile X Syndrome and Its Treatments
Author Information
Author(s): Gillett Drew A., Tigro Helene, Wang Yuan, Suo Zucai
Primary Institution: Department of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, FL, USA
Hypothesis
This review aims to provide an overview of FMR1 biology and the latest research focused on developing therapeutic interventions for Fragile X Syndrome (FXS).
Conclusion
Current treatments for FXS only manage symptoms, and no cure exists, highlighting the need for further research into effective therapies.
Supporting Evidence
- Fragile X Syndrome is the most common cause of inherited intellectual disability.
- Current pharmacological and therapy options only manage symptoms of FXS.
- Research indicates that no cure for FMR1 disorders currently exists.
Takeaway
Fragile X Syndrome is a genetic condition that affects how people think and behave, and while there are ways to help manage the symptoms, there is no cure yet.
Methodology
This is a review article summarizing existing research on FMR1 disorders and potential therapeutic strategies.
Limitations
The review does not present original data and relies on existing literature, which may have its own limitations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website